It is high time for Europe to break its relative decline in the pharmaceutical sector. Europe used to be the preeminent region in the world for Research and Development and innovation in the sector - being the location for a majority of R&D and the development of new medicines. However, its...

While innovation is central for the quality of healthcare and improving health outcomes, it is also a source of increasing costs for governments. Confronted by fiscal pressures, governments have made efforts to restrict access to innovative treatments. While such policies are understandable,...

While innovation is central for the quality of healthcare and improving health outcomes, it is also a source of increasing costs for governments. Confronted by fiscal pressures, governments have made efforts to restrict access to innovative treatments. While such policies are understandable,...

It is high time for Europe to break its relative decline in the pharmaceutical sector. Europe used to be the preeminent region in the world for Research and Development and innovation in the sector - being the location for a majority of R&D and the development of new medicines. However, its...

Cover page -- Halftitle page -- Title page -- Copyright page -- CONTENTS -- LIST OF FIGURES -- PREFACE -- ACKNOWLEDGMENTS -- 1 INTRODUCTION -- The planning machine -- Bound capitalism -- The four horsemen of capitalist decline -- 2 WHEN CAPITALISM BECAME MIDDLE-AGED -- The bridges to Maddison...

The EU stands at a crucial economic juncture. Economic growth in Europe's mature economies has stagnated, with productivity and other indicators of economic vitality showing poor results. Public debt is alarmingly high in several countries, and the region faces new fiscal demands due to an...